PE20020792A1 - Antagonistas de receptores de aminoacidos excitadores - Google Patents
Antagonistas de receptores de aminoacidos excitadoresInfo
- Publication number
- PE20020792A1 PE20020792A1 PE2002000003A PE2002000003A PE20020792A1 PE 20020792 A1 PE20020792 A1 PE 20020792A1 PE 2002000003 A PE2002000003 A PE 2002000003A PE 2002000003 A PE2002000003 A PE 2002000003A PE 20020792 A1 PE20020792 A1 PE 20020792A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- refers
- acid
- antagonists
- amino acid
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title abstract 2
- 102000015404 Amino Acid Receptors Human genes 0.000 title 1
- 108010025177 Amino Acid Receptors Proteins 0.000 title 1
- -1 ISOQUINOLINE COMPOUND Chemical class 0.000 abstract 3
- 239000002253 acid Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- AWJUIBRHMBBTKR-UHFFFAOYSA-N iso-quinoline Natural products C1=NC=CC2=CC=CC=C21 AWJUIBRHMBBTKR-UHFFFAOYSA-N 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 201000006474 Brain Ischemia Diseases 0.000 abstract 1
- 206010008120 Cerebral ischaemia Diseases 0.000 abstract 1
- 206010021143 Hypoxia Diseases 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 210000004556 brain Anatomy 0.000 abstract 1
- 230000000747 cardiac effect Effects 0.000 abstract 1
- 206010008118 cerebral infarction Diseases 0.000 abstract 1
- 230000007954 hypoxia Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- 208000020431 spinal cord injury Diseases 0.000 abstract 1
- 238000001356 surgical procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26001401P | 2001-01-05 | 2001-01-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20020792A1 true PE20020792A1 (es) | 2002-09-06 |
Family
ID=22987455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2002000003A PE20020792A1 (es) | 2001-01-05 | 2002-01-04 | Antagonistas de receptores de aminoacidos excitadores |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1351955A1 (enExample) |
| JP (1) | JP2004520335A (enExample) |
| KR (1) | KR20030066797A (enExample) |
| CN (1) | CN1484642A (enExample) |
| AR (1) | AR035679A1 (enExample) |
| BR (1) | BR0116672A (enExample) |
| CA (1) | CA2431545A1 (enExample) |
| CZ (1) | CZ20031856A3 (enExample) |
| DZ (1) | DZ3460A1 (enExample) |
| EA (1) | EA200300770A1 (enExample) |
| EC (1) | ECSP034682A (enExample) |
| HR (1) | HRP20030544A2 (enExample) |
| HU (1) | HUP0302528A2 (enExample) |
| IL (1) | IL156138A0 (enExample) |
| MX (1) | MXPA03005981A (enExample) |
| NO (1) | NO20032973D0 (enExample) |
| NZ (1) | NZ525821A (enExample) |
| PE (1) | PE20020792A1 (enExample) |
| PL (1) | PL361934A1 (enExample) |
| SK (1) | SK8242003A3 (enExample) |
| TW (1) | TW591023B (enExample) |
| WO (1) | WO2002053561A1 (enExample) |
| ZA (1) | ZA200304311B (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5284957A (en) * | 1992-09-03 | 1994-02-08 | Eli Lilly And Company | Excitatory amino acid receptor antagonists |
| EP1053234A1 (en) * | 1998-02-06 | 2000-11-22 | Smithkline Beecham Plc | Salts of paroxetine |
| GB9908175D0 (en) * | 1999-04-09 | 1999-06-02 | Lilly Co Eli | Method of treating neurological disorders |
| DZ3209A1 (fr) * | 1999-07-06 | 2001-01-11 | Lilly Co Eli | Antagonistes selectifs du recepteur iGLuR5 utilises dans le traitement de la migraine. |
-
2001
- 2001-12-20 CZ CZ20031856A patent/CZ20031856A3/cs unknown
- 2001-12-20 EA EA200300770A patent/EA200300770A1/ru unknown
- 2001-12-20 JP JP2002554680A patent/JP2004520335A/ja active Pending
- 2001-12-20 EP EP01995980A patent/EP1351955A1/en not_active Withdrawn
- 2001-12-20 CA CA002431545A patent/CA2431545A1/en not_active Abandoned
- 2001-12-20 MX MXPA03005981A patent/MXPA03005981A/es unknown
- 2001-12-20 DZ DZ013460A patent/DZ3460A1/fr active
- 2001-12-20 BR BR0116672-7A patent/BR0116672A/pt not_active IP Right Cessation
- 2001-12-20 PL PL01361934A patent/PL361934A1/xx not_active Application Discontinuation
- 2001-12-20 SK SK824-2003A patent/SK8242003A3/sk unknown
- 2001-12-20 CN CNA018217508A patent/CN1484642A/zh active Pending
- 2001-12-20 KR KR10-2003-7008977A patent/KR20030066797A/ko not_active Withdrawn
- 2001-12-20 HU HU0302528A patent/HUP0302528A2/hu unknown
- 2001-12-20 WO PCT/US2001/044715 patent/WO2002053561A1/en not_active Ceased
- 2001-12-20 IL IL15613801A patent/IL156138A0/xx unknown
- 2001-12-20 NZ NZ525821A patent/NZ525821A/en unknown
- 2001-12-20 HR HR20030544A patent/HRP20030544A2/hr not_active Application Discontinuation
-
2002
- 2002-01-04 PE PE2002000003A patent/PE20020792A1/es not_active Application Discontinuation
- 2002-01-04 TW TW091100071A patent/TW591023B/zh not_active IP Right Cessation
- 2002-01-04 AR ARP020100030A patent/AR035679A1/es not_active Application Discontinuation
-
2003
- 2003-06-02 ZA ZA200304311A patent/ZA200304311B/en unknown
- 2003-06-27 NO NO20032973A patent/NO20032973D0/no not_active Application Discontinuation
- 2003-07-03 EC EC2003004682A patent/ECSP034682A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL361934A1 (en) | 2004-10-18 |
| MXPA03005981A (es) | 2003-09-10 |
| WO2002053561A1 (en) | 2002-07-11 |
| BR0116672A (pt) | 2003-09-23 |
| CA2431545A1 (en) | 2002-07-11 |
| KR20030066797A (ko) | 2003-08-09 |
| DZ3460A1 (fr) | 2002-07-11 |
| TW591023B (en) | 2004-06-11 |
| EA200300770A1 (ru) | 2003-10-30 |
| NO20032973L (no) | 2003-06-27 |
| HRP20030544A2 (en) | 2004-08-31 |
| ECSP034682A (es) | 2003-08-29 |
| ZA200304311B (en) | 2004-09-02 |
| CZ20031856A3 (cs) | 2003-09-17 |
| HUP0302528A2 (hu) | 2003-11-28 |
| SK8242003A3 (en) | 2004-01-08 |
| NZ525821A (en) | 2004-07-30 |
| NO20032973D0 (no) | 2003-06-27 |
| IL156138A0 (en) | 2003-12-23 |
| AR035679A1 (es) | 2004-06-23 |
| EP1351955A1 (en) | 2003-10-15 |
| JP2004520335A (ja) | 2004-07-08 |
| CN1484642A (zh) | 2004-03-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20230249A1 (es) | Compuestos de heteroarilo biciclicos y usos de estos | |
| ES2702474T3 (es) | Ciclohexilmetanosulfonamidas | |
| MX2010003346A (es) | Piperazino-dihidrotienopirimidinas sustituidas en heterociclo. | |
| PE20120418A1 (es) | DERIVADOS DE PIRIDO[2,3-b]PIRAZINA COMO INHIBIDORES DE POLI (ADP-RIBOSA) POLIMERASA (PARP) | |
| PE20060570A1 (es) | Compuestos de quinazolina e isoquinolina piperidilo sustituidos como inhibidores de fosfodiesterasa pde-10 | |
| PE20020721A1 (es) | Derivados de quinuclidina como agentes antimuscarinicos m3 | |
| PL1716152T3 (pl) | Skondensowane związki heterocykliczne i ich zastosowanie jako antagonistów receptora metabotropowego do leczenia zaburzeń żołądkowo-jelitowych | |
| CA2534571A1 (en) | Substituted isoquinoline derivatives and methods of use | |
| NO20062139L (no) | Dihydrobenzofuranyl-alkanaminderivater som 5HT2C-agonister | |
| ECSP088293A (es) | Inhibidores de gamma secretasa, de sulfonamido n-cíclico puenteado | |
| TW200519096A (en) | Quinazoline analogs as receptor tyrosine kinase inhibitors | |
| AR053566A1 (es) | Compuestos espiriciclicos antagonistas de los receptores de trombina | |
| TWI662019B (zh) | Fused tricyclic γ-amino acid derivative, preparation method and application thereof in medicine | |
| ATE399770T1 (de) | Tachykininrezeptorantagonisten | |
| EA200500173A1 (ru) | Производные 3,6-дизамещенного азабицикло[3.1.0]гексана в качестве антагонистов мускариновых рецепторов | |
| NO985518L (no) | Morfinanderivater og medisinsk anvendelse derav | |
| PE20010299A1 (es) | DERIVADOS DE DECAHIDROISOQUINOLINA COMO ANTAGONISTAS SELECTIVOS DEL RECEPTOR iGLUR5 | |
| PE20080176A1 (es) | Compuestos de arilpiperazina sulfonamida como agonista de los receptores de secretagogos de la hormona de crecimiento (ghs) | |
| EA200201158A1 (ru) | Бициклические циклогексиламины и их применение в качестве антагонистов nmda-рецепторов | |
| AR054611A1 (es) | Antagonistas del receptor de trombina y composicion farmaceutica | |
| AR058728A1 (es) | Derivados de aril-isoxazol-4-il-imidazo[1,5-a]piridina, metodo de preparacion,medicamentos que los contienen y usos en el tratamiento de trastornos cognitivos. | |
| CA2925743A1 (en) | Novel bicyclic pyridinones as gamma-secretase modulators | |
| MX2007005199A (es) | Indolizinas sustituidas y derivados como agentes del sistema nervioso central. | |
| PE43795A1 (es) | Compuesto neuroprotector | |
| UY27680A1 (es) | Agonistas del receptor b3 - andrenérgicos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |